Progress in Understanding the Role of Probiotics and Fecal Microbiota Transplantation in Regulating Inflammatory Bowel Disease

被引：0
|
作者：
Tian Y. [1 ]
Zhang C. [1 ]
Yang T. [1 ]
Dai X. [1 ]
Liu W. [1 ]
Man C. [1 ]
Zhang W. [1 ]
Jiang Y. [1 ]
机构：
[1] Key Laboratory of Dairy Science, Ministry of Education, School of Food Science, Northeast Agricultural University, Harbin
来源：
Jiang, Yujun (yujun_jiang@163.com) | 1600年 / Chinese Chamber of Commerce卷 / 42期
关键词：
Crohn's disease; Fecal microbiota transplantation; Gut microbiota; Inflammatory bowel diseases; Intestinal barrier; Probiotics; Ulcerative colitis;
D O I：
10.7506/spkx1002-6630-20200914-166
中图分类号：
学科分类号：
摘要：
Inflammatory bowel disease (IBD) is a chronic and recurrent gastrointestinal inflammatory disease, whose incidence is increasing worldwide in recent years. Its pathogenesis is complicated, which is mainly caused by the interaction of genetic, environmental and immune factors. Intensive studies of the host-gut microbial interaction have demonstrated that the intestinal microflora plays an important role in the development of IBD. Therefore, there is tremendous interest in developing new methods to relieve and treat IBD by regulating the gut microbiota. In recent years, a large number of studies have proved that probiotics and fecal microbiota transplantation (FMT) may alleviate IBD by regulating the composition of intestinal microflora, enhancing the mucosal barrier function and regulating the immune response. This article reviews the recent progress in the pathogenesis of IBD and the application of probiotics and fecal bacteria transplantation on IBD. © 2021, China Food Publishing Company. All right reserved.
引用
收藏
页码：250 / 259
页数：9
相关论文
共 104 条
  • [31] YILMAZ B, JUILLERAT P, OYAS O, Et al., Microbial network disturbances in relapsing refractory Crohn's disease, Nature Medicine, 25, 2, pp. 323-336, (2019)
  • [32] SOKOL H, PIGNEUR B, WATTERLOT L, Et al., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients, Proceedings of the National Academy of Sciences, 105, 43, pp. 16731-16736, (2008)
  • [33] VARELA E, MANICHANH C, GALLART M, Et al., Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis, Alimentary Pharmacology &Therapeutics, 38, 2, pp. 151-161, (2013)
  • [34] GEVERS D, KUGATHASAN S, DENSON L A, Et al., The treatmentnaive microbiome in new-onset Crohn's disease, Cell Host &Microbe, 15, 3, pp. 382-392, (2014)
  • [35] RAJILIC S M, SHANAHAN F, GUARNER F, Et al., Phylogenetic analysis of dysbiosis in ulcerative colitis during remission, Inflammatory Bowel Diseases, 19, 3, pp. 481-488, (2013)
  • [36] BAUMGART M, DOGAN B, RISHNIW M, Et al., Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of clostridiales in Crohn's disease involving the ileum, The ISME Journal, 1, 5, pp. 403-418, (2007)
  • [37] OKAYASU I, HATAKEYAMA S, YAMADA M, Et al., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology, 98, 3, pp. 694-702, (1990)
  • [38] HAKANSSON A, TORMOBADIA N, BARIDI A, Et al., Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice, Clinical and Experimental Medicine, 15, 1, pp. 107-120, (2015)
  • [39] ETTREIKI C, GADONNA W P, MANGIN I, Et al., Juvenile ferric iron prevents microbiota dysbiosis and colitis in adult rodents, World Journal of Gastroenterology, 18, 21, pp. 2619-2629, (2012)
  • [40] YANG B, CHEN H Q, GAO H, Et al., Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation, Journal of Functional Foods, 49, pp. 61-72, (2018)
12345678910